Products will be introduced by New Canadian Distribution Partner MINNEAPOLIS, March 22 (HSMN NewsFeed) — ATS Pharmaceutical, Inc. (Nasdaq:ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced that Health…
Devices, Cardiology, Regulatory
ATS Clinical, ATS Simulus, Annuloplasty

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “ATS Laboratory Receives Approval to Commercialize the ATS Simulus Annuloplasty Products in Canada”
Leave a Comment